Nexwin Pharma Pvt. Ltd. is a growing pharmaceutical company offering Pharma Franchise opportunities for Injection Products across India. Based in Panchkula, Haryana, the company has developed a broad pharmaceutical portfolio covering tablets, capsules, softgels, syrups, eye and ear drops, injectables, IV infusions, sachets, and other healthcare formulations.

The company has a dedicated Injectables & IV Infusions range featuring a wide selection of injectable formulations across different therapeutic applications. Its portfolio includes antibiotics, anti-infective injections, corticosteroid injections, nutritional formulations, critical-care products, and IV infusions. The company's official product listing includes formulations such as Merospark, Sparxone, Vancospar, Clindacef, Mixipred, and several other injectable products.

Nexwin Pharma provides PCD franchise opportunities supported by monopoly rights, promotional materials, marketing assistance, product availability, and timely delivery. The company states that it follows WHO-GMP and ISO-certified manufacturing standards and offers DCGI-approved pharmaceutical products.

With a diversified product portfolio, dedicated injectable range, and franchise support system, Nexwin Pharma provides business opportunities for pharmaceutical distributors and entrepreneurs looking to enter the injectable and IV infusion segment. Its focus on product quality, reliable supply, and nationwide franchise support makes it a suitable choice for those searching for a Pharma Franchise Company for Injections in India.